A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

<p>Abstract</p> <p>Background</p> <p>Peritoneal carcinomatosis is regarded as a common sign of advanced tumor stage, tumor progression or local recurrence of appendiceal and colorectal cancer and is generally associated with poor prognosis. Although survival of patients...

Full description

Bibliographic Details
Main Authors: Glockzin Gabriel, Rochon Justine, Arnold Dirk, Lang Sven A, Klebl Frank, Zeman Florian, Koller Michael, Schlitt Hans J, Piso Pompiliu
Format: Article
Language:English
Published: BMC 2013-02-01
Series:BMC Cancer
Subjects:
Cytoreductive surgery
HIPEC
Perioperative chemotherapy
Cetuximab
Colorectal cancer
Peritoneal carcinomatosis
Online Access:http://www.biomedcentral.com/1471-2407/13/67

Internet

http://www.biomedcentral.com/1471-2407/13/67

Similar Items